Home/Hedge Fund Intelligence/Jazz Pharmaceuticals plc
Nasdaq: JAZZStockForm 13F30 Jun 2026

Hedge funds that hold Jazz Pharmaceuticals plc Usd Nasdaq: JAZZ

Usd · CUSIP G50871105 · who reports it, how much, and how much it matters to them

31 of the 720 hedge fund managers we track reported shares of Jazz Pharmaceuticals plc (Nasdaq: JAZZ) on Form 13F for 30 June 2026. Between them they reported USD 1.1bn. The largest position belongs to Citadel Advisors, at USD 243m. The manager with the most riding on it is GMT Capital, where it is 5.7% of the reported book.

Managers reporting it31of 720 we track
Value they reportUSD 1.1bnshares only, 30 Jun 2026
Funds they run615with a file on PPLI.com
Largest positionUSD 243mCitadel Advisors
Typical weight0.1%median share of a manager's book
Heaviest weight5.7%GMT Capital

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

31 managers, USD 1.1bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Jazz Pharmaceuticals plc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Citadel Advisors32 funds on PPLI.comUSD 243m0.0%
2Millennium Management6 funds on PPLI.comUSD 184m0.1%
3Renaissance Technologies13 funds on PPLI.comUSD 135m0.2%
4GMT Capital3 funds on PPLI.comUSD 109m5.7%
5Two Sigma Investments35 funds on PPLI.comUSD 96m0.1%
6Sofinnova Investments1 fund on PPLI.comUSD 88m4.6%
7GoldenTree Asset Management31 funds on PPLI.comUSD 71m4.1%
8Perceptive Advisors6 funds on PPLI.comUSD 41m0.6%
9Holocene Advisors2 funds on PPLI.comUSD 39m0.1%
10PFM Health Sciences3 funds on PPLI.comUSD 39m3.3%
11D. E. Shaw & Co.15 funds on PPLI.comUSD 21m0.0%
12Schonfeld Strategic Advisors30 funds on PPLI.comUSD 19m0.1%
13Exoduspoint Capital Management7 funds on PPLI.comUSD 13m0.1%
14Squarepoint Ops7 funds on PPLI.comUSD 13m0.0%
15Marshall Wace LLP84 funds on PPLI.comUSD 8.4m0.0%
16Ardsley Advisory Partners6 funds on PPLI.comUSD 7.2m0.8%
17Cercano Management5 funds on PPLI.comUSD 4.2m0.6%
18Lighthouse Investment Partners190 funds on PPLI.comUSD 3.6m0.1%
19Atom Investors1 fund on PPLI.comUSD 3.2m0.3%
20Weiss Asset Management5 funds on PPLI.comUSD 2.9m0.0%
21Castleknight Management3 funds on PPLI.comUSD 2.9m0.0%
22Engineers Gate Manager1 fund on PPLI.comUSD 1.5m0.0%
23Capricorn Fund Managers8 funds on PPLI.comUSD 1.5m0.1%
24Fora Capital1 fund on PPLI.comUSD 1.3m0.1%
25Wolverine Asset Management1 fund on PPLI.comUSD 561,0000.0%
26Balyasny Asset Management25 funds on PPLI.comUSD 487,0000.0%
27CIBC Asset Management69 funds on PPLI.comUSD 459,0000.0%
28Aquatic Capital Management3 funds on PPLI.comUSD 456,0000.0%
29BTG Pactual Asset Management US11 funds on PPLI.comUSD 350,0000.0%
30Persistent Asset Partners10 funds on PPLI.comUSD 280,0000.1%
31The Quarry1 fund on PPLI.comUSD 2,1690.0%
Next: where it matters most
Where it matters most

For GMT Capital it is 5.7% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1GMT CapitalUSD 109m5.7%
2Sofinnova InvestmentsUSD 88m4.6%
3GoldenTree Asset ManagementUSD 71m4.1%
4PFM Health SciencesUSD 39m3.3%
5Ardsley Advisory PartnersUSD 7.2m0.8%
6Perceptive AdvisorsUSD 41m0.6%
7Cercano ManagementUSD 4.2m0.6%
8Atom InvestorsUSD 3.2m0.3%
9Renaissance TechnologiesUSD 135m0.2%
10Capricorn Fund ManagersUSD 1.5m0.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Jazz Pharmaceuticals plc

What is the ticker symbol of Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc trades under the symbol JAZZ on the Nasdaq. Its CUSIP, the code used on Form 13F, is G50871105.

Which hedge funds own Jazz Pharmaceuticals plc (Nasdaq: JAZZ)?

31 of the 720 hedge fund managers PPLI.com tracks reported Jazz Pharmaceuticals plc shares on Form 13F for 30 June 2026. The largest reported positions were held by Citadel Advisors (USD 243m), Millennium Management (USD 184m), Renaissance Technologies (USD 135m), GMT Capital (USD 109m) and Two Sigma Investments (USD 96m).

How many hedge funds hold Jazz Pharmaceuticals plc?

31 managers in our coverage reported it, and between them they run 615 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Jazz Pharmaceuticals plc?

GMT Capital, where the position was 5.7% of the reported 13F book at 30 June 2026.

Does this show who is short Jazz Pharmaceuticals plc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Jazz Pharmaceuticals plc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.